Investigational Drug Details
| Drug ID: | D047 |
| Drug Name: | BMS-986251 |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | 132123624 |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | S(=O)(=O)([C@]12[C@H](N(CC1)C(=O)[C@H]1[C@H](C[C@@H](CC1)C(=O)O)C)CCc1c2ccc(c1)C(F)(C(F)(F)F)C(F)(F)F)c1ccc(F)cc1 |
| Structure: |
|
| InChiKey: | JQORWGARJVSRBA-QOTTZFGFSA-N |
| Molecular Weight: | 667.615 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | RORGt inverse agonist |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 1&2 terminated (NCT03329885: Adverse change in the risk/benefit) |
| Latest Progress: | Failed in clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0809 | NCT03329885 | Phase 1/Phase 2 | Not recruiting | Has Results | 31/10/2017 | 12 December 2020 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|